CLBS Annual Net Income
-$27.47 M
-$19.32 M-237.01%
31 December 2021
Summary:
As of February 2, 2025, CLBS annual net profit is -$27.47 million, with the most recent change of -$19.32 million (-237.01%) on December 31, 2021. During the last 3 years, it has fallen by -$11.30 million (-69.89%).CLBS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Quarterly Net Income
-$37.38 M
-$30.76 M-464.19%
01 September 2022
Summary:
As of February 2, 2025, CLBS quarterly net profit is -$37.38 million, with the most recent change of -$30.76 million (-464.19%) on September 1, 2022. Over the past year, it has dropped by -$30.46 million (-439.67%).CLBS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS TTM Net Income
-$55.03 M
-$30.46 M-123.94%
01 September 2022
Summary:
As of February 2, 2025, CLBS TTM net profit is -$55.03 million, with the most recent change of -$30.46 million (-123.94%) on September 1, 2022. Over the past year, it has dropped by -$28.93 million (-110.81%).CLBS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -237.0% | -439.7% | -110.8% |
| 3 y3 years | -69.9% | -663.2% | -184.2% |
| 5 y5 years | -219.5% | -990.4% | -184.2% |
CLBS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -219.5% | -196.5% | -300.5% |
Caladrius Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$37.38 M(+464.2%) | -$55.03 M(+123.9%) |
| June 2022 | - | -$6.63 M(+56.8%) | -$24.57 M(+4.0%) |
| Mar 2022 | - | -$4.23 M(-37.8%) | -$23.63 M(-14.0%) |
| Dec 2021 | -$27.47 M(+237.0%) | -$6.79 M(-1.9%) | -$27.47 M(+5.2%) |
| Sept 2021 | - | -$6.93 M(+21.9%) | -$26.10 M(+6.5%) |
| June 2021 | - | -$5.68 M(-29.5%) | -$24.50 M(+100.5%) |
| Mar 2021 | - | -$8.06 M(+48.5%) | -$12.22 M(+50.0%) |
| Dec 2020 | -$8.15 M(-57.9%) | -$5.43 M(+2.0%) | -$8.15 M(+6.2%) |
| Sept 2020 | - | -$5.33 M(-180.7%) | -$7.67 M(+5.9%) |
| June 2020 | - | $6.60 M(-265.4%) | -$7.25 M(-61.8%) |
| Mar 2020 | - | -$3.99 M(-19.5%) | -$18.98 M(-1.9%) |
| Dec 2019 | -$19.36 M(+19.8%) | -$4.96 M(+1.2%) | -$19.36 M(+7.8%) |
| Sept 2019 | - | -$4.90 M(-4.7%) | -$17.96 M(+8.1%) |
| June 2019 | - | -$5.14 M(+17.7%) | -$16.61 M(+6.8%) |
| Mar 2019 | - | -$4.37 M(+22.7%) | -$15.55 M(-3.8%) |
| Dec 2018 | -$16.17 M(-170.4%) | -$3.56 M(+0.2%) | -$16.17 M(+4.5%) |
| Sept 2018 | - | -$3.55 M(-12.9%) | -$15.47 M(+0.8%) |
| June 2018 | - | -$4.08 M(-18.2%) | -$15.35 M(-155.9%) |
| Mar 2018 | - | -$4.98 M(+74.0%) | $27.45 M(+19.0%) |
| Dec 2017 | $22.98 M(-170.4%) | -$2.86 M(-16.5%) | $23.07 M(+15.5%) |
| Sept 2017 | - | -$3.43 M(-108.9%) | $19.97 M(+20.9%) |
| June 2017 | - | $38.72 M(-513.7%) | $16.52 M(-155.0%) |
| Mar 2017 | - | -$9.36 M(+57.1%) | -$30.04 M(-8.0%) |
| Dec 2016 | -$32.66 M(-59.6%) | -$5.96 M(-13.4%) | -$32.66 M(-45.5%) |
| Sept 2016 | - | -$6.88 M(-12.2%) | -$59.89 M(-7.0%) |
| June 2016 | - | -$7.83 M(-34.6%) | -$64.39 M(-12.6%) |
| Mar 2016 | - | -$11.98 M(-63.9%) | -$73.68 M(-8.9%) |
| Dec 2015 | -$80.89 M(+47.4%) | -$33.20 M(+191.8%) | -$80.89 M(+36.4%) |
| Sept 2015 | - | -$11.38 M(-33.6%) | -$59.30 M(-8.6%) |
| June 2015 | - | -$17.13 M(-10.7%) | -$64.90 M(+7.5%) |
| Mar 2015 | - | -$19.19 M(+65.2%) | -$60.38 M(+10.0%) |
| Dec 2014 | -$54.87 M(+40.8%) | -$11.61 M(-31.6%) | -$54.87 M(-1.7%) |
| Sept 2014 | - | -$16.97 M(+34.7%) | -$55.80 M(+16.5%) |
| June 2014 | - | -$12.61 M(-7.9%) | -$47.89 M(+9.2%) |
| Mar 2014 | - | -$13.68 M(+9.2%) | -$43.86 M(+12.5%) |
| Dec 2013 | -$38.98 M(-27.5%) | -$12.53 M(+38.2%) | -$38.98 M(-7.1%) |
| Sept 2013 | - | -$9.07 M(+5.8%) | -$41.95 M(+1.6%) |
| June 2013 | - | -$8.58 M(-2.6%) | -$41.29 M(-22.4%) |
| Mar 2013 | - | -$8.80 M(-43.2%) | -$53.22 M(-1.0%) |
| Dec 2012 | -$53.77 M(+14.1%) | -$15.51 M(+84.3%) | -$53.77 M(-5.9%) |
| Sept 2012 | - | -$8.41 M(-59.0%) | -$57.11 M(+1.9%) |
| June 2012 | - | -$20.51 M(+119.4%) | -$56.05 M(+21.5%) |
| Mar 2012 | - | -$9.35 M(-50.4%) | -$46.15 M(-1.8%) |
| Dec 2011 | -$47.13 M(+102.2%) | -$18.85 M(+156.5%) | -$46.97 M(+36.9%) |
| Sept 2011 | - | -$7.35 M(-30.7%) | -$34.30 M(+0.6%) |
| June 2011 | - | -$10.61 M(+4.3%) | -$34.10 M(+18.1%) |
| Mar 2011 | - | -$10.17 M(+64.6%) | -$28.87 M(+23.9%) |
| Dec 2010 | -$23.31 M | -$6.18 M(-13.5%) | -$23.31 M(-21.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$7.14 M(+32.9%) | -$29.52 M(-0.3%) |
| June 2010 | - | -$5.37 M(+16.5%) | -$29.60 M(+2.4%) |
| Mar 2010 | - | -$4.61 M(-62.8%) | -$28.92 M(+10.5%) |
| Dec 2009 | -$26.17 M(+183.2%) | -$12.39 M(+71.7%) | -$26.17 M(+61.5%) |
| Sept 2009 | - | -$7.22 M(+53.9%) | -$16.21 M(+48.5%) |
| June 2009 | - | -$4.69 M(+151.3%) | -$10.91 M(+27.1%) |
| Mar 2009 | - | -$1.87 M(-23.2%) | -$8.58 M(-7.1%) |
| Dec 2008 | -$9.24 M(-11.5%) | -$2.43 M(+26.5%) | -$9.24 M(+1.0%) |
| Sept 2008 | - | -$1.92 M(-18.6%) | -$9.15 M(-20.8%) |
| June 2008 | - | -$2.36 M(-6.5%) | -$11.56 M(+3.6%) |
| Mar 2008 | - | -$2.53 M(+7.9%) | -$11.16 M(+6.8%) |
| Dec 2007 | -$10.45 M(+72.6%) | -$2.34 M(-45.9%) | -$10.45 M(+4.9%) |
| Sept 2007 | - | -$4.33 M(+121.0%) | -$9.96 M(+33.9%) |
| June 2007 | - | -$1.96 M(+7.8%) | -$7.44 M(+10.6%) |
| Mar 2007 | - | -$1.82 M(-2.2%) | -$6.73 M(+11.2%) |
| Dec 2006 | -$6.05 M(+246.8%) | -$1.86 M(+2.8%) | -$6.05 M(+28.2%) |
| Sept 2006 | - | -$1.81 M(+45.2%) | -$4.72 M(+35.3%) |
| June 2006 | - | -$1.25 M(+9.3%) | -$3.49 M(+32.3%) |
| Mar 2006 | - | -$1.14 M(+116.2%) | -$2.63 M(+51.0%) |
| Dec 2005 | -$1.75 M(-0.2%) | -$527.00 K(-8.4%) | -$1.75 M(+15.0%) |
| Sept 2005 | - | -$575.40 K(+46.4%) | -$1.52 M(+5.2%) |
| June 2005 | - | -$393.10 K(+57.4%) | -$1.44 M(-6.4%) |
| Mar 2005 | - | -$249.70 K(-16.6%) | -$1.54 M(-11.8%) |
| Dec 2004 | -$1.75 M(+67.5%) | -$299.50 K(-40.2%) | -$1.75 M(-7.9%) |
| Sept 2004 | - | -$500.50 K(+1.7%) | -$1.90 M(+18.5%) |
| June 2004 | - | -$492.20 K(+7.9%) | -$1.60 M(+18.0%) |
| Mar 2004 | - | -$456.20 K(+1.5%) | -$1.36 M(+30.0%) |
| Dec 2003 | -$1.04 M(-10.0%) | -$449.60 K(+120.4%) | -$1.04 M(+7.5%) |
| Sept 2003 | - | -$204.00 K(-17.6%) | -$971.00 K(-1.5%) |
| June 2003 | - | -$247.60 K(+73.1%) | -$986.00 K(+1.3%) |
| Mar 2003 | - | -$143.00 K(-62.0%) | -$973.00 K(-16.1%) |
| Dec 2002 | -$1.16 M(-43.0%) | -$376.40 K(+71.9%) | -$1.16 M(-22.5%) |
| Sept 2002 | - | -$219.00 K(-6.6%) | -$1.50 M(-8.7%) |
| June 2002 | - | -$234.60 K(-28.9%) | -$1.64 M(-4.8%) |
| Mar 2002 | - | -$329.80 K(-53.7%) | -$1.72 M(-15.3%) |
| Dec 2001 | -$2.03 M(+0.3%) | -$712.50 K(+96.8%) | -$2.03 M(+9.6%) |
| Sept 2001 | - | -$362.00 K(+13.9%) | -$1.86 M(-23.6%) |
| June 2001 | - | -$317.80 K(-50.4%) | -$2.43 M(-2.1%) |
| Mar 2001 | - | -$640.90 K(+19.9%) | -$2.48 M(+22.4%) |
| Dec 2000 | -$2.03 M(+82.3%) | -$534.70 K(-42.9%) | -$2.03 M(+35.8%) |
| Sept 2000 | - | -$935.70 K(+153.0%) | -$1.49 M(+168.0%) |
| June 2000 | - | -$369.90 K(+97.9%) | -$556.80 K(+197.9%) |
| Mar 2000 | - | -$186.90 K | -$186.90 K |
| Dec 1999 | -$1.11 M(+148.5%) | - | - |
| Dec 1998 | -$447.60 K(+69.6%) | - | - |
| Mar 1998 | -$263.90 K(-20.7%) | - | - |
| Mar 1997 | -$332.60 K(-119.4%) | - | - |
| Mar 1996 | $1.71 M | - | - |
FAQ
- What is Caladrius Biosciences annual net profit?
- What is the all time high annual net income for Caladrius Biosciences?
- What is Caladrius Biosciences annual net income year-on-year change?
- What is Caladrius Biosciences quarterly net profit?
- What is the all time high quarterly net income for Caladrius Biosciences?
- What is Caladrius Biosciences quarterly net income year-on-year change?
- What is Caladrius Biosciences TTM net profit?
- What is the all time high TTM net income for Caladrius Biosciences?
- What is Caladrius Biosciences TTM net income year-on-year change?
What is Caladrius Biosciences annual net profit?
The current annual net income of CLBS is -$27.47 M
What is the all time high annual net income for Caladrius Biosciences?
Caladrius Biosciences all-time high annual net profit is $22.98 M
What is Caladrius Biosciences annual net income year-on-year change?
Over the past year, CLBS annual net profit has changed by -$19.32 M (-237.01%)
What is Caladrius Biosciences quarterly net profit?
The current quarterly net income of CLBS is -$37.38 M
What is the all time high quarterly net income for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly net profit is $38.72 M
What is Caladrius Biosciences quarterly net income year-on-year change?
Over the past year, CLBS quarterly net profit has changed by -$30.46 M (-439.67%)
What is Caladrius Biosciences TTM net profit?
The current TTM net income of CLBS is -$55.03 M
What is the all time high TTM net income for Caladrius Biosciences?
Caladrius Biosciences all-time high TTM net profit is $27.45 M
What is Caladrius Biosciences TTM net income year-on-year change?
Over the past year, CLBS TTM net profit has changed by -$28.93 M (-110.81%)